SEC Form 4 · accession 0001822629-26-000014
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nikhil Lalwani
Officer — PRESIDENT & CEO · Director
Period of report
Aug 25, 2026
Accepted (ET)
Aug 26, 2026 · 6:15 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 25, 2026 | S | 5,400 | $74.30 | D | 344,489 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026.
- F2The shares were sold in multiple trades at prices ranging from $73.58 to $74.61. The price reported above reflects the weighted average sales price.